CLINICAL_TRIALS
trial_result
· 2013-11-06
Clinical Trial Update: Spiriva® Assessment of FEV1 (SAFE) [Phase 3]
Summary
The Phase 3 SAFE trial evaluating Spiriva (tiotropium) for FEV1 assessment in chronic obstructive pulmonary disease has completed. The entry provides the trial …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED